期刊文献+

环磷酰胺冲击治疗儿童难治性斯蒂尔病的疗效 被引量:2

Efficiency of Pulse Cyclophosphamide in the Treatment of Severe Still' s Disease in Children
下载PDF
导出
摘要 目的观察环磷酰胺冲击治疗儿童难治性斯蒂尔病的疗效。方法环磷酰胺每次700~750mg/m2,每2~4周1次静脉滴注,疗程3~6月,总剂量150mg/kg,予以疗效评估,并随访6月~3年。结果10例难治性斯蒂尔病患儿均完成疗程,其中显效者4例,有效者5例,无效者1例,总有效率达90%。治疗过程中3例出现不良反应。结论环磷酰胺冲击治疗儿童难治性斯蒂尔病具有较好的疗效。 Objective To investigate the effect of pulse cyclophosphamide treatment in severe Still' s disease children. Methods The total dose of intravenous cyclophosphamide was 150 mg/kg and 700 - 750 mg/m2 per course. The median interval between the courses treatment for cyclophosphamide was 3 weeks (range, 2 to 4). Each total course was 3 to 6 months. We assessed the efficacy of cyclophosphamide and reported the 6 months to 3 years follow-up investigation. Results Ten severe Still's disease patients finished the whole course of treatment. Four patients achieved satisfaction response, and five partial response, and one no response. The overall effective rate was 90% . Three cases had toxic reaction response. Conclusion Cyclophosphamide is effective in the treatment of severe Still's disease in children.
出处 《上海第二医科大学学报》 CSCD 北大核心 2005年第3期295-296,308,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 治疗 难治性 斯蒂尔病 环磷酰胺冲击 疗效 儿童 疗程 剂量 children Still' s disease cyclophosphamide
  • 相关文献

参考文献10

  • 1Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic nnset juve-nile rheumatoid arthritis [ J ]. Arthritis Rheum, 1997,40(10) : 1852 -1855.
  • 2Boykinov IN, Stefanov S, Ivanova N, et al. Association of chronic oligoarthritis with Hla class ii alleles: drbl, dqbl and dqal in bulgarian children[J]. Ann Rheum Dis, 2001, 60 (Suppl. 1) : Ⅱ17- Ⅱ52.
  • 3Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders [ J ]. Arch Dis Child, 2001, 85(5) : 421 -426.
  • 4Sathananthan R, David J. The adolescent with rheumatic disease [J]. Arch Dis Child, 1997, 77(4): 355 -358.
  • 5Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R, et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide[J]. Br J rheumatol, 1995, 34:737 -741.
  • 6Wang CL, Wang F, Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus[ J ]. Lupus, 1995,4:11-14.
  • 7Boumpas DT, Austin HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy [ J ]. X Ann Intern Med, 1993, 119:366-369.
  • 8Sato M, Takeda A, Honzu H, et al. Adult Still' s disease with Sjogren's syndrome successfully treated with intravenous pulse methylprednisolone and oral cyclophosphamide [ J ]. Intern Med,1993, 32(9) : 730 -732.
  • 9Chaouat D, Belange G, Gompel H. Efficiency of cyclophosphamide bolus in Still' s disease in adults [ J ]. Rev Rhum Mal Osteoartic,1992, 59(4) :285 -287.
  • 10杨少锋,周秩林,吴启富,刘毅,张玉勋,乔贵林,殷震.显微注射法建成HLA-B_(27)转基因大鼠[J].第一军医大学学报,1999,19(2):108-110. 被引量:2

二级参考文献1

  • 1田小利,转基因动物原理、技术与应用,1994年,22页

共引文献1

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部